Oral salmon calcitonin: Phase I/II

UGNE reported that in a trial of180 osteoporotic women comparing UGNE's oral

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE